聚焦艾昆纬-推进中枢神经系统临床试验的数字健康技术(DHT)(第一部分)(英)-2026。scores, while the normal latency group did not. The authors noted a more pronounced placebo response within the normal latency group and suggested that enriching the trial for slow latency participants would increase observed treatment effect sizes by 52 to 100%depending on treatment arm.17。
聚焦艾昆纬-推进中枢神经系统临床试验的数字健康技术(DHT)(第一部分)(英)-2026。scores, while the normal latency group did not. The authors noted a more pronounced placebo response within the normal latency group and suggested that enriching the trial for slow latency participants would increase observed treatment effect sizes by 52 to 100%depending on treatment arm.17。
聚焦艾昆纬-推进中枢神经系统临床试验的数字健康技术(DHT)(第一部分)(英)-2026。scores, while the normal latency group did not. The authors noted a more pronounced placebo response within the normal latency group and suggested that enriching the trial for slow latency participants would increase observed treatment effect sizes by 52 to 100%depending on treatment arm.17。
覆盖 2026 年,全文共 11 页。
本报告为付费报告,可在资料宝站内下单后获取完整内容。
重点分析了临床、健康、艾昆纬、DHT等议题。